The most common adverse events are gastrointestinal in nature, including nausea (20-47% depending on dose), constipation (21%), fatigue (20%), and vomiting (8%)
illustrated by Pete Jeffs
Cardiovascular outcome trials have further demonstrated that GLP-1 agonists like semaglutide reduce major adverse cardiac events in patients with established heart disease or diabetes
CVS Health owns Aetna, and CVS Caremark manages Aetna's pharmacy benefits
In addition to appetite suppression, semaglutide GLP-1 slows gastric emptying, meaning that food remains in the stomach longer, enhancing the feeling of satiety after meals
The most GLP-1-friendly foods of all, Wiseman says, are those that come with no labels, like produce and water